Study On Financing Risk Control Of Our Country’ Pharmaceutical Industry

Financing is the sources of enterprise funds, is all subsequent investment activities, businessactivities as a foundation, success to raise funds, the enterprise can smoothly each project, forenterprises to realize profits target. But, the market conditions in the twinkling of an eye, once andenterprise financing related conditions change, brings to the enterprise financing risk is notnegligible. Along with the progress of the high and new technology, the development of theenterprise of our country medicine space expands unceasingly, the enterprise must spend a lot ofmoney to satisfy the requirements of the market. But the pharmaceutical industry drug developmentat the need to invest a lot of money, the development results of great uncertainty, once thedevelopment failure, initial investment will not return; If successfully developed, productproduction stage also requires plenty of money. High investment, high risk and high income hasbecome the pronoun of pharmaceutical enterprise, the industry will face pressure has become thefinancing that limit the development of the important factors. And, in the enterprise financing entireprocess, from the industry itself and the surrounding environment all aspects of factors, will affectthe enterprise financing efficiency. Therefore, our country medicine enterprise financing to solveproblems, how will the enterprise’s financial risk control in the reasonable scope has theoreticalsignificance of reality.This article mainly from the financing the related theory began, such as capital structure, risk,financing risk characteristics and classification, etc.; Then, from the features of the pharmaceuticalindustry, the industry financing analysis of the current situation, find out the cause of the financingrisk specific factors, emphatically from the enterprise internal factors and external factors of; Finally,in view of these factors, puts forward the preventive and control measures of financing risk.